Eric Warren, Chief Commercial Officer: Esperion Therapeutics ESPR Sell · Filed 24/06/20

Trade details

Type: Insider sale
Amount: $7,264.4
Shares · price: 2,540 sh · $2.86 a share
Held after: 165,586 sh
Stock: Esperion Therapeutics ESPR
Person: Eric WarrenChief Commercial Officer
Trade date: 24/06/18
Filed: 24/06/20
Days to filing: 2 days

Sold 1.5% of holdings

Share of holding sold: 1.5%

Esperion Therapeutics trades, last 26 weeks

What else happened in Esperion Therapeutics around then

Filed or reported within 30 days of the trade day · 24/05/19~24/07/18

Eric Warren's recent trades

Eric WarrenChief Commercial Officer
Planned sale10b5-1 planMineralys Therapeutics
Planned sale10b5-1 plan
Mineralys Therapeutics
MLYS
$209.1K
7,438 sh
$209.1K
Filed 09/21
Traded 09/21
Eric WarrenChief Commercial Officer
Planned sale10b5-1 planMineralys Therapeutics
Planned sale10b5-1 plan
Mineralys Therapeutics
MLYS
$193.2K
7,437 sh
$193.2K
Filed 08/21
Traded 08/21
Eric WarrenChief Commercial Officer
Planned sale10b5-1 planMineralys Therapeutics
Planned sale10b5-1 plan
Mineralys Therapeutics
MLYS
$199.9K
7,438 sh
$199.9K
Filed 07/21
Traded 07/21
Eric WarrenChief Commercial Officer
Sell10b5-1 planMineralys Therapeutics
Sell10b5-1 plan
Mineralys Therapeutics
MLYS
$2.7M
104,124 sh
$2.7M
Filed 06/30
Traded 06/26
Eric WarrenChief Commercial Officer
Planned sale10b5-1 planMineralys Therapeutics
Planned sale10b5-1 plan
Mineralys Therapeutics
MLYS
$2.7M
104,124 sh
$2.7M
Filed 06/29
Traded 06/26

Eric Warren, Chief Officer — sold $7,264 of Esperion Therapeutics ESPR · 1.5% of holdings | Whalegun